NASDAQ
1.06USD
+0.02 (+1.92%)
Dots are scored news catalysts — size = impact, color = sentiment. Tap one to read it.
Market cap
46.8M
P/E
—
EPS
—
Beta
1.74
52W range
0.99-2.9
Day range
1.03–1.09
Open
1.05
Prev close
1.04
Volume
53.4K
Avg volume
203.5K
Dividend
0.00
IPO
2021-04-28
No scored news tagged BTMD or its network in the window yet.
Show more BTMD articles →Biote Corp. is dedicated to supporting and developing medical practices that focus on hormone optimization. The company provides a comprehensive system for its Biote-certified healthcare professionals, enabling them to correct imbalances in patients' hormone, vitamin, and mineral levels. This includes authorizing the prescription of bioidentical hormone treatments and suggesting suitable dietary supplements. Furthermore, Biote offers its own line of branded nutritional supplements and supplies sterile kits for inserting hormone pellets for both male and female individuals. Founded in 2011, Biote Corp. is based in Irvine, Texas.
Daily OHLCV with SMA overlays and session pivots. Draw your levels and trendlines on it, or ask the AI analyst what the price is reacting to.
Suppliers, customers, partners and competitors, derived from what the news actually says about biote Corp. — not a sector bucket. Click an edge to see the articles that established the link.
Latest scored catalyst for BTMD: .
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
